ImageProVision
Science & Engineering · Biotechnology
$4Mlatest round · Convertible Note · Sep 2021 · 5 yr ago
$1Mrevenue · 2024 · SEC Form D 0002048548-25-000001
10+team · employees, estimated range
3cities with offices
Overview
AI-powered image analysis software for particle characterization, vial inspection, microbial counting & quality control. Trusted by 200+ pharma & life sciences leaders globally.
Funding and backers
Total raised
$4M
1 round on record
Latest round
$4M
Convertible Note · Sep 2021 · 5 yr ago
Team
11-50
employees, estimated range
Revenue
$1M
2024 · SEC Form D 0002048548-25-000001
The money's age
Long since its last round
61 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Sep 2021 | $4M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ImageProVision, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Raghu RaoExecutive Officer, DirectorSEC Form D
Jeffrey HallExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Industry 5.0 AI solutions for workplace safety, process automation, and quality control. Trusted by 150+ global enterprises. Real-time…

Learn about T2D2 and our leaders. As well as how our software empowers organizations with greater insight into their facade inspection…

Get mobile plans that scale with your business across borders. One contract, one invoice, total control. Trusted by global teams.

About Genesis Where Life Science Leaders Connect, Collaborate, and Create Impact For more than two decades, Genesis has united key opinion…

Use AI to detect, monitor, and inspect. Save up to 99.7% of your time with AI based satellite, aerial and drone image analysis.

Bluenote. Accelerate regulatory submissions by 50-75% with advanced AI for life sciences. Trusted by the industry's largest pharma, medical…
Financials
Est. Annual Revenue
$500k
2024
Total raised
$4M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2021 | $4M | Details |
People

Raghu Rao
Executive Officer, Director

Jeffrey Hall
Executive Officer

Sandeep Kulkarni
Director

Devendra Shukla
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Kingston
United States
HQ
Pune
India
Regional office
3rd Floor, D.S. Ikon, Survey No.22, Laxman Nagar, Baner, Pune – 411045, India.
Princeton
United States
Regional office
DISSO INDIA 2025 – Certificate of Recognition
303A College Road East, Princeton Innovation Center - BioLabs, Princeton, NJ 08540, USA






